Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.14 USD | +2.09% | +4.51% | -12.61% |
Apr. 18 | NeoGenomics, Inc. Announces Senior Leadership Promotions | CI |
Apr. 18 | NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics | CI |
Business Summary
Number of employees: 2,100
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Clinical Services
83.8
%
| 419 | 82.2 % | 496 | 83.8 % | +18.36% |
Advanced Diagnostics
16.2
%
| 91 | 17.8 % | 96 | 16.2 % | +5.53% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 510 | 100.0 % | 592 | 100.0 % | +16.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chris Smith
CEO | Chief Executive Officer | 61 | 22-08-14 |
Lynn Tetrault
CHM | Chairman | 61 | 15-06-11 |
Jeffrey Sherman
DFI | Director of Finance/CFO | 58 | 22-12-06 |
Derek Lyle
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Chief Tech/Sci/R&D Officer | 57 | 22-03-06 | |
Greg Sparks
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Hutan Hashemi
CMP | Compliance Officer | 45 | 22-02-28 |
Chief Tech/Sci/R&D Officer | - | - | |
Melody Harris
COO | Chief Operating Officer | 58 | 22-12-04 |
Steven Ross
CTO | Chief Tech/Sci/R&D Officer | 60 | 13-04-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Crowther
BRD | Director/Board Member | 72 | 14-10-21 |
Michael Kelly
BRD | Director/Board Member | 67 | 20-07-14 |
Chris Smith
CEO | Chief Executive Officer | 61 | 22-08-14 |
David Perez
BRD | Director/Board Member | 63 | 22-11-02 |
Anthony Zook
BRD | Director/Board Member | 63 | 23-06-25 |
Lynn Tetrault
CHM | Chairman | 61 | 15-06-11 |
Stephen Kanovsky
BRD | Director/Board Member | 61 | 17-07-18 |
Alison Hannah
BRD | Director/Board Member | 63 | 15-06-11 |
Neil Gunn
BRD | Director/Board Member | 63 | 23-06-25 |
Director/Board Member | 48 | 23-06-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 127,665,638 | 126,162,754 ( 98.82 %) | 0 | 98.82 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.61% | 1.81B | |
-17.89% | 8.25B | |
+39.20% | 3.57B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-7.35% | 2.38B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B | |
-15.34% | 1.03B |
- Stock Market
- Equities
- NEO Stock
- Company NeoGenomics, Inc.